SEMA/OZEM 5mg: The GLP-1 Agonist for Weight and Blood Sugar Control

SEMA/OZEM (Semaglutide) is a GLP-1 receptor agonist whose effectiveness is extensively documented in clinical research for weight management and type 2 diabetes. Its long-acting formulation allows for weekly administration while maintaining stable therapeutic levels.

How Does SEMA/OZEM Work?

Semaglutide mimics the action of natural GLP-1 hormone by binding to its receptors in the brain, intestine and pancreas. It reduces hunger, slows gastric emptying and stimulates glucose-dependent insulin secretion, creating a hormonal environment favorable to weight loss and glycemic control.

Scientifically Documented Benefits

Weight Control

• Average 15% weight loss in STEP studies
• Marked reduction in appetite and hunger sensation
• Decrease in compulsive eating behaviors

Glycemic Control

• Significant reduction in HbA1c
• Improved insulin sensitivity
• Postprandial blood sugar stabilization

Cardiovascular Protection

• Reduced risk of major cardiovascular events
• Improved systolic blood pressure
• Positive effects on triglycerides and LDL

Kidney Health

• Documented nephroprotective effects
• Reduction of albuminuria

Recommended Dosage

• Dose: 5mg
• Frequency: 1 injection per week
• Route of administration: subcutaneous injection
• Duration: 16 to 68 weeks depending on the protocol

Possible Side Effects

• Nausea at the start of treatment (transient and dose-dependent)
• Mild digestive issues
• Consult a healthcare professional before starting

For laboratory research use only.
Bacteriostatic water required for reconstitution. See our starter kit.